Live tape
CellLight-directed evolution of dynamic, multi-state, and computational protein functionalitiesCellSelective targeting of endothelial and perivascular angiocrine ROCK2 treats liver fibrosisCellDynamics of natural selection preceding human viral epidemics and pandemicsCellDeltaviruses spread through a viral Trojan HorseCellβ-hydroxybutyrate enhances the metabolic fitness of CAR T cells in cancerIlluminaAssessing Illumina (ILMN) Valuation After Recent Share Price Weakness - simplywall.stLonza NewsWill Lonza Group AG (Common Stock) (LO3A) stock beat growth indexes - Short Setup & Smart Investment Allocation Tips - Naître et grandirThermo FisherNeo Ivy Capital Management Buys 3,865 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeatIlluminaNeo Ivy Capital Management Invests $1.83 Million in Illumina, Inc. $ILMN - MarketBeatEndpoints NewsUniQure’s dispute with FDA; Zealand’s obesity readout; China takes on world’s most expensive medicines; and moreWatersRep. Kevin Hern Shares of Waters Corporation (NYSE:WAT) - MarketBeatLonza NewsLonza sells off its capsules division to British firm - SWI swissinfo.ch
Illumina Jan 20, 2026

Medicare to cover $2,989.55 Illumina genomic cancer test - Stock Titan

Medicare to cover $2,989.55 Illumina genomic cancer test - Stock Titan

Open original source
Full body text is not stored for this item yet. Use the original source to continue reading.
Directory ribbon

Brand directory, kept in view

A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.

Open about page